Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
45,349,616
-
Share change
-
+16,770,976
-
Total reported value
-
$30,110,233
-
Price per share
-
$0.66
-
Number of holders
-
38
-
Value change
-
+$10,980,521
-
Number of buys
-
16
-
Number of sells
-
13
Institutional Holders of ALIGOS THERAPEUTICS INC - COM NEW (ALGS) as of Q4 2023
As of 31 Dec 2023,
ALIGOS THERAPEUTICS INC - COM NEW (ALGS) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,349,616 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, EcoR1 Capital, LLC, Deep Track Capital, LP, Vivo Capital, LLC, Alyeska Investment Group, L.P., Altitude Crest Partners Inc., Versant Venture Management, LLC, TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, and HHLR ADVISORS, LTD..
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.